Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Critical review of nucleic acid nanotechnology to identify gaps and inform a strategy for accelerated clinical translation

Advanced Drug Delivery Reviews(2021)10.1016/j.addr.2021.114081Source: DataRank Database

Critical review of nucleic acid nanotechnology to identify gaps and inform a strategy for accelerated clinical translation is a research paper published in Advanced Drug Delivery Reviews (2021). On theSindex it has a DataRank of 0. It has been cited 68 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access68 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (20 grants)Topics (31)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Marina A. Dobrovolskaia ORCID,Weina Ke,Piotr Grodzinski ORCID,Mark Bathe ORCID,Kirill A. Afonin ORCID

Live enrichment

PubMed:34915069 PMC:PMC8886801

Army Research Office

Grant: W911NF-13-D-0001

National Science Foundation

Grant: CBET-1729397

National Science Foundation

Grant: CCF-1564025

National Institutes of Health

Grant: 75N91019D00024

National Institutes of Health

Grant: HHSN261200800001E

Office of Naval Research

Grant: N00014-20-1-2084

Office of Naval Research

Grant: N00014-21-1-4013

National Institute of General Medical Sciences

Grant: R01-MH112694

National Institute of General Medical Sciences

Grant: R01GM120487

National Institute of General Medical Sciences

Grant: R21-EB026008-S1

National Institute of General Medical Sciences

Grant: R35GM139587

CCR NIH HHS

Grant: HHSN261200800001C

NIMH NIH HHS

Grant: R01 MH112694

NIBIB NIH HHS

Grant: R21 EB026008

National Institutes of Health

Grant: 5R01GM120487-04

Characterization of various multifunctional nucleic acid nanoparticles and understanding their immunotoxicity

National Science Foundation

Grant: 1729397

DMREF: Computational Design of Next-generation Nanoscale DNA-based Materials

National Institutes of Health

Grant: 1R01MH112694-01

Simultaneous multiplexed in situ fluorescence imaging of neuronal proteins and messenger RNAs

National Institutes of Health

Grant: 1R21EB026008-01

Structured DNA Nanoparticles Therapeutic mRNA and CRISPR/Cas9 Delivery

National Institutes of Health

Grant: 3R35GM139587-03S1

Administrative Supplement to SMART NANPs: new molecular platform for communication with human immune system and modulation of therapeutic responses

National Cancer Institute

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

AnimalsHumansNucleic AcidsImmunotherapyDrug Delivery SystemsNanotechnologyNanoparticlesCOVID-19SARS-CoV-2COVID-19 VaccinesCOVID-19 Drug Treatment

Keywords

VaccineNon-viral vectorDna OrigamiTherapeutic Nucleic AcidsNucleic Acid NanotechnologyCOVID-19 VaccinesSARS-CoV-2COVID-19ArticleCOVID-19 Drug TreatmentDrug Delivery SystemsNucleic AcidsAnimalsHumansNanoparticlesNanotechnologyImmunotherapy

Sustainable Development Goals

SDG 3: 3. Good health